Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BioPsychoSocial Medicine
Published in: BioPsychoSocial Medicine 1/2019

Open Access 01-12-2019 | Antidepressant Drugs | Review

Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review

Authors: Trang T. H. Tu, Miho Takenoshita, Hirofumi Matsuoka, Takeshi Watanabe, Takayuki Suga, Yuma Aota, Yoshihiro Abiko, Akira Toyofuku

Published in: BioPsychoSocial Medicine | Issue 1/2019

Login to get access

Abstract

Burning Mouth Syndrome (BMS), a chronic intraoral burning sensation or dysesthesia without clinically evident causes, is one of the most common medically unexplained oral symptoms/syndromes. Even though the clinical features of BMS have been astonishingly common and consistent throughout the world for hundreds of years, BMS remains an enigma and has evolved to more intractable condition. In fact, there is a large and growing number of elderly BMS patients for whom the disease is accompanied by systemic diseases, in addition to aging physical change, which makes the diagnosis and treatment of BMS more difficult. Because the biggest barrier preventing us from finding the core pathophysiology and best therapy for BMS seems to be its heterogeneity, this syndrome remains challenging for clinicians. In this review, we discuss currently hopeful management strategies, including central neuromodulators (Tricyclic Antidepressants - TCAs, Serotonin, and Norepinephrine Reuptake Inhibitors - SNRIs, Selective Serotonin Reuptake Inhibitors - SSRIs, Clonazepam) and solutions for applying non-pharmacology approaches. Moreover, we also emphasize the important role of patient education and anxiety management to improve the patients’ quality of life. A combination of optimized medication with a short-term supportive psychotherapeutic approach might be a useful solution.
Literature
1.
Merskey H, Bogduk N. Classification of Chronic Pain. 2nd ed. Seattle, WA: IASP Press;. Descriptions of chronic pain syndromes and definitions of pain terms;1994 p.74.
2.
3.
Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician. 2002;65(4):615–20.PubMed
4.
Forssell H, Jääskeläinen S, List T, Svensson P, Baad-Hansen L. An update on pathophysiological mechanisms related to idiopathic oro-facial pain conditions with implications for management. J Oral Rehabil. 2015;42(4):300–22.PubMedCrossRef
5.
Steele JC. The practical evaluation and management of patients with symptoms of a sore burning mouth. Clin Dermatol. 2016;34(4):449–57.PubMedCrossRef
6.
Patton LL, Siegel MA, Benoliel R, de Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 2007;103(suppl.39):S39.e1–S39.e13.
7.
8.
9.
Charleston L 4th. Burning mouth syndrome: a review of recent literature. Curr Pain Headache Rep. 2013;17(6):336.PubMedCrossRef
10.
11.
Moghadam-Kia S, Fazel N. A diagnostic and therapeutic approach to primary burning mouth syndrome. Clin Dermatol. 2017;35(5):453–60.PubMedCrossRef
12.
Suga T, Watanabe T, Aota Y, Nagamine T, Toyofuku A. Burning mouth syndrome: the challenge of an aging population. Geriatr Gerontol Int 2018: Article in Press.
13.
Breckons M, Shen J, Bunga J, Vale L, Study DJDEEP. Indirect and out-of-pocket costs of persistent orofacial pain. J Dent Res. 2018.
14.
Yap T, McCullough M. Oral medicine and the ageing population. Aust Dent J. 2015;60(Suppl 1):44–53.PubMedCrossRef
15.
The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018,38(1):178.
16.
Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2012;123(1):71–7.PubMedCrossRef
17.
Kohorst JJ, Bruce AJ, Torgerson RR, Schenck LA, Davis MD. The prevalence of burning mouth syndrome: a population-based study. Br J Dermatol. 2015;172(6):1654–6.PubMedPubMedCentralCrossRef
18.
Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28(8):350–4.PubMedCrossRef
19.
20.
Takenoshita M, Sato T, Kato Y, et al. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat. 2010;6:699–705.PubMedPubMedCentral
21.
Tu TTH, Miura A, Shinohara Y, Mikuzuki L, Kawasaki K, Sugawara S, Suga T, Watanabe T, Watanabe M, Umezaki Y, Yoshikawa T, Motomura H, Takenoshita M, Toyofuku A. Evaluating burning mouth syndrome as a comorbidity of atypical Odontalgia: the impact on pain experiences. Pain Pract. 2017;18(5):580–6.PubMedCrossRef
22.
Abetz LM, Savage NW. Burning mouth syndrome and psychological disorders. Aust Dent J. 2009;54(2):84–93.PubMedCrossRef
23.
de Souza FT, Teixeira AL, Amaral TM, dos Santos TP, Abreu MH, Silva TA, Kummer A. Psychiatric disorders in burning mouth syndrome. J Psychosom Res. 2012;72(2):142–6.PubMedCrossRef
24.
25.
Leimola-Virtanen R, et al. Expression of estrogen receptor (ER) in oral mucosa and salivary glands. Maturitas. 2000;36:131–7.PubMedCrossRef
26.
Grushka M, et al. Taste dysfunction in burning mouth syndrome. Gerodontics. 1988;4:256–8.PubMed
27.
Jääskeläinen SK. Clinical neurophysiology and quantitative sensory testing in the investigation of orofacial pain and sensory function. J Orofac Pain. 2004;18(2):85–107.PubMed
28.
Neblett R, Cohen H, Choi Y, Hartzell MM, Williams M, Mayer TG, Gatchel RJ. The central sensitization inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14(5):438–45.PubMedPubMedCentralCrossRef
29.
30.
Jääskeläinen SK. Is burning mouth syndrome a neuropathic pain condition? Pain. 2018;159(3):610–3.PubMed
31.
32.
Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Toyofuku A. Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years. Neuropsychiatr Dis Treat. 2018;14:2057–65.PubMedPubMedCentralCrossRef
33.
34.
Khan SA, Keaser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome. Pain. 2014;155(8):1472–80.PubMedCrossRef
35.
Shinozaki T, Imamura Y, Kohashi R, Dezawa K, Nakaya Y, Sato Y, Watanabe K, Morimoto Y, Shizukuishi T, Abe O, Haji T, Tabei K, Taira M. Spatial and temporal brain responses to noxious heat thermal stimuli in burning mouth syndrome. J Dent Res. 2016;95(10):1138–46.PubMedCrossRef
36.
Yoshino A, Okamoto Y, Doi M, Okada G, Takamura M, Ichikawa N, Yamawaki S. Functional alterations of postcentral gyrus modulated by angry facial expressions during intraoral tactile stimuli in patients with burning mouth syndrome: a functional magnetic resonance imaging Study. Front Psychiatry. 2017;6(8):224.CrossRef
37.
Wada A, Shizukuishi T, Kikuta J, Yamada H, Watanabe Y, Imamura Y, Shinozaki T, Dezawa K, Haradome H, Abe O. Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography. Neuroradiology. 2017;59(5):525–32.PubMedCrossRef
38.
Katagiri A, Sato Y, Umezaki Y, Sato T, Watanabe M, Takenoshita M, Yoshikawa T, Toyofuku A. Burning mouth Syndrome in an aged patient with Alzheimer's Disease : A case report. Jpn J Psychosom Dent. 2011;26(1):36–40 (article in Japanese).
39.
Feller L, Fourie J, Bouckaert M, Khammissa RAG, Ballyram R, Lemmer J. Burning mouth syndrome: Aetiopathogenesis and principles of management. Pain Res Manag. 2017:1926269.
40.
Tait RC, Ferguson M, Herndon CM. Chronic orofacial pain: burning mouth syndrome and other neuropathic disorders. J Pain Manag Med 2017;3(1). pii:120.
41.
Mignogna MD, Fedele S, Lo Russo L, Leuci S, Lo Muzio L. The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain. 2005;19(2):168–73.PubMed
42.
Häggman-Henrikson B, Alstergren P, Davidson T, Högestätt ED, Östlund P, Tranaeus S, Vitols S, List T. Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta- analysis. J Oral Rehabil. 2017;44(10):800–26.PubMedCrossRef
43.
Fischoff D, Spivakovsky S. Are pharmacological treatments for oro-facial pain effective? Evid Based Dent. 2018 Mar 23;19(1):28–9.PubMedCrossRef
44.
45.
McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev. 2016;11:CD002779.PubMed
46.
Fischoff DK, Spivakovsky S. Little evidence to support or refute interventions for the management of burning mouth syndrome. Evid Based Dent. 2017;18(2):57–8.PubMedCrossRef
47.
48.
Toye F. Not everything that can be counted counts and not everything that counts can be counted' (attributed to Albert Einstein). Br J Pain. 2015;9(1):7.PubMedPubMedCentralCrossRef
49.
50.
51.
Peciña M, Bohnert AS, Sikora M, Avery ET, Langenecker SA, Mickey BJ, Zubieta JK. Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression. JAMA Psychiatry. 2015;72(11):1087–94.PubMedPubMedCentralCrossRef
52.
de Souza IF, Mármora BC, Rados PV, Visioli F. Treatment modalities for burning mouth syndrome: a systematic review. Clin Oral Investig. 2018;22(5):1893–905.PubMedCrossRef
53.
Toyofuku A. From psychosomatic dentistry to brain dentistry. Kokubyo Gakkai Zasshi 2007;74(3):161–168. (Article in Japanese).
54.
Fenelon M, Quinque E, Arrive E, Catros S, Fricain JC. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study. Int J Oral Maxillofac Surg. 2017;46(11):1505–11.PubMedCrossRef
55.
Kawasaki K, Nagamine T, Watanabe T, Suga T, Tu TTH, Sugawara S, Mikuzuki L, Miura A, Shinohara Y, Yoshikawa T, Takenoshita M, Toyofuku A. An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome. Asia Pac Psychiatry. 2018;25:e12315.CrossRef
56.
Takeshi Watanabe, Kaoru Kawasaki, Trang T.H Tu, Takayuki Suga, Shiori Sugawara, Lou Mikuzuki, Anna Miura, Yukiko Shinohara, Tatsuya Yoshikawa, Miho Takenoshita, Akira Toyofuku, Takahiko Nagamine, The QTc shortening with amitriptyline may indicate treatment resistance in chronic nonorganic orofacial pain. Clinical Neuropsychopharmacology and Therapeutics, Released April 10, 2018, Online ISSN 1884–8826, Print ISSN.
57.
Toyofuku A. Efficacy of milnacipran for glossodynia patients. Int J Psychiatry Clin Pract. 2003;7(Suppl 1):23–4.PubMedCrossRef
58.
Kato Y, Sato T, Katagiri A, Umezaki Y, Takenoshita M, Yoshikawa T, Sato Y, Toyofuku A. Milnacipran dose-effect study in patients with burning mouth syndrome. Clin Neuropharmacol. 2011;34(4):166–9.PubMedCrossRef
59.
Mitsikostas DD, Ljubisavljevic S, Deligianni CI. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities. treatment and outcome J Headache Pain. 2017;18(1):40.
60.
Nagamine T. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain. Psychiatry Clin Neurosci. 2018;72(1):45–6.PubMedCrossRef
61.
Riediger C, Schuster T, Barlinn K, Maier S, Weitz J, Siepmann T. Adverse effects of antidepressants for chronic pain: a systematic review and Meta-analysis. Front Neurol. 2017;8:307.PubMedPubMedCentralCrossRef
62.
Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut−brain interaction): a Rome Foundation working team report. Gastroenterology 2018;154:1140–1171.
63.
Takenoshita M, Motomura H, Toyofuku A. Low-dose aripiprazole augmentation in amitriptyline-resistant burning mouth syndrome: results from two cases. Pain Med. 2017;18(4):814–5.PubMedPubMedCentral
64.
65.
Jimenez XF, Sundararajan T, Covington EC. A systematic review of atypical antipsychotics in chronic pain management: olanzapine demonstrates potential in central sensitization, fibromyalgia, and headache/migraine. Clin J Pain. 2018;34(6):585–91.PubMedCrossRef
66.
Heckmann SM, Kirchner E, Grushka M, Wichmann MG. Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122(4):813–6.PubMedCrossRef
67.
Kuten-Shorrer M, Treister NS, Stock S, Kelley JM, Ji YD, Woo SB, Lerman MA, Palmason S, Sonis ST, Villa A. Topical clonazepam solution for the Management of Burning Mouth Syndrome: a retrospective Study. J Oral Facial Pain Headache. 2017;31(3):257–63.PubMedCrossRef
68.
Goodman CW, Brett AS. Gabapentin and Pregabalin for pain - is increased prescribing a cause for concern? N Engl J Med. 2017;377(5):411–4.PubMedCrossRef
69.
Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med. 1995;24(5):213–5.PubMedCrossRef
70.
Femiano F, Gombos F, Scully C. Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid). and combination therapy Med Oral. 2004;9(1):8–13.
71.
Komiyama O, Nishimura H, Makiyama Y, et al. Group cognitive-behavioral intervention for patients with burning mouth syndrome. J Oral Sci. 2013;55(1):17–22.PubMedCrossRef
72.
Wergeland GJ, Fjermestad KW, Marin CE, et al. An effectiveness study of individual vs. group cognitive behavioral therapy for anxiety disorders in youth. Behav Res Ther. 2014;57:1–12.PubMedCrossRef
73.
Matsuoka H, Himachi M, Furukawa H, et al. Cognitive profile of patients with burning mouth syndrome in the Japanese population. Odontology. 2010;98(2):160–4.PubMedCrossRef
74.
Matsuoka H, Chiba I, Sakano Y, Toyofuku A, Abiko Y. Cognitive behavioral therapy for psychosomatic problems in dental settings. Biopsychosoc Med. 2017;13(11):18.CrossRef
75.
Brailo V, Firić M, Vučićević Boras V, Andabak Rogulj A, Krstevski I, Alajbeg I. Impact of reassurance on pain perception in patients with primary burning mouth syndrome. Oral Dis. 2016;22(6):512–6.PubMedCrossRef
76.
Lopez-Jornet P, Lucero-Berdugo M, Castillo-Felipe C, Zamora Lavella C, Ferrandez-Pujante A, Pons-Fuster A. Assessment of self-reported sleep disturbance and psychological status in patients with burning mouth syndrome. J Eur Acad Dermatol Venereol. 2015;29(7):1285–90.PubMedCrossRef
77.
Cheatle MD, Foster S, Pinkett A, Lesneski M, Qu D, Dhingra L. Assessing and managing sleep disturbance in patients with chronic pain. Sleep Med Clin. 2016;11(4):531–41.PubMedCrossRef
78.
Lami MJ, Martínez MP, Miró E, et al. Efficacy of combined cognitive- behavioral therapy for insomnia and pain in patients with fibromyalgia: a randomized controlled trial. Cogn Ther Res. 2018;42(1):63–79.CrossRef
79.
Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47–56.PubMedCrossRef
80.
Yamazaki Y, Hata H, Kitamori S, Onodera M, Kitagawa Y. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):e6–11.PubMedCrossRef
81.
Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational interviewing improves medication adherence: a systematic review and Meta- analysis. J Gen Intern Med. 2016;31(8):929–40.PubMedPubMedCentralCrossRef
82.
Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind Study. Brain Stimul. 2016;9(2):234–42.PubMedCrossRef
83.
Umezaki Y, Badran BW, Gonzales TS, George MS. Daily left prefrontal repetitive transcranial magnetic stimulation for medication-resistant burning mouth syndrome. Int J Oral Maxillofac Surg. 2015;44(8):1048–51.PubMedCrossRef
84.
Suda S, Takagai S, Inoshima-Takahashi K, Sugihara G, Mori N, Takei N. Electroconvulsive therapy for burning mouth syndrome. Acta Psychiatr Scand. 2008;118(6):503–4.PubMedCrossRef
85.
McGirr A, Davis L, Vila-Rodriguez F. Idiopathic burning mouth syndrome: a common treatment-refractory somatoform condition responsive to ECT. Psychiatry Res. 2014;216(1):158–9.PubMedCrossRef
86.
Li BY, Tang HD, Qiao Y, Chen SD. Mental training for cognitive improvement in elderly people: what have we learned from clinical and neurophysiologic studies? Curr Alzheimer Res. 2015;12(6):543–52.PubMedCrossRef
87.
LeBlanc A, Herrin J, Williams MD, Inselman JW, Branda ME, Shah ND, Heim EM, Dick SR, Linzer M, Boehm DH, Dall-Winther KM, Matthews MR, Yost KJ, Shepel KK, Montori VM. Shared decision making for antidepressants in primary care: a cluster randomized trial. JAMA Intern Med. 2015;175(11):1761–70.PubMedPubMedCentralCrossRef
88.
Van Damme S, Becker S, Van Der Linden D. Tired of pain? Toward a better understanding of fatigue in chronic pain. Pain. 2018;159:7–10.PubMedCrossRef
89.
Solberg LI, Crain AL, Rubenstein L, Unützer J, Whitebird RR, Beck A. How much shared decision making occurs in usual primary care of depression? J Am Board Fam Med. 2014;27(2):199–208.PubMedCrossRef
Metadata
Title
Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review
Authors
Trang T. H. Tu
Miho Takenoshita
Hirofumi Matsuoka
Takeshi Watanabe
Takayuki Suga
Yuma Aota
Yoshihiro Abiko
Akira Toyofuku
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BioPsychoSocial Medicine / Issue 1/2019
Electronic ISSN: 1751-0759
DOI
https://doi.org/10.1186/s13030-019-0142-7

Other articles of this Issue 1/2019

BioPsychoSocial Medicine 1/2019 Go to the issue

Research

Validation of a childhood eating disorder outcome scale

Research

Attitude of pregnant women towards Normal delivery and factors driving use of caesarian section in Iran (2016)

Research

Developing a Japanese version of the Injustice Experience Questionnaire-chronic and the contribution of perceived injustice to severity of menstrual pain: a web-based cross-sectional study

Research

Subjective well-being and problem-solving skills for alleviating the stress of elderly men attending a randomized controlled trial of shogi-assisted cognitive behavioral therapy

Review

Potential benefits of integrating ecological momentary assessment data into mHealth care systems

Research

Weight loss in conservative treatment of obesity in women is associated with physical activity and circadian phenotype: a longitudinal observational study